This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: Mendelian randomization based on immune cells in diabetic nephropathy
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsChronic Kidney Disease and Diabetes · Renal Diseases and Glomerulopathies · Machine Learning in Healthcare
The journal retracts the August 06 2024 article cited above.
Following publication, concerns were raised regarding the scientific validity of the article. An investigation was conducted in accordance with Frontiers’ policies.
It was found that the complaints were valid and that the article does not meet the standards of editorial and scientific soundness for Frontiers in Endocrinology; therefore, the article has been retracted.
This retraction was approved by the Chief Editors of Frontiers in Endocrinology and the Chief Executive Editor of Frontiers. The authors did not provide a response to this Retraction.